(Q41613849)

English

Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions

scientific article published on January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions (English)

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

primary metabolite

1 reference

based on heuristic

inferred from title

author name string

C Prakash

1

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

A Kamel

2

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

D Cui

3

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

R D Whalen

4

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

J J Miceli

5

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

D Tweedie

6

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

49 Suppl 1

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

35S-42S

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Measurement of protein using bicinchoninic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

The molecular biology of cytochrome P450s.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

The rational selection of drug interaction studies: implications of recent advances in drug metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

8 Kinetic analysis of progress curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

6 June 2018

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

17 June 2018

Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

19 August 2018

Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism of the beta-carbolines harmine and harmol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015052

19 August 2018

Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

49 Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding consequences of concurrent therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of in vitro human metabolism studies in drug development. An industrial perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10771452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2000.00151.X

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41613849&oldid=1762012020"